UK Pharmaceutical Supplier to Sri Lanka
Sri Lanka's National Medicines Regulatory Authority (NMRA) controls medicine registration, import and quality standards under the National Medicines Regulatory Authority Act No. 5 of 2015. For unregistered medicines required for specific patient cases, NMRA operates a waiver system allowing import on a case-by-case basis. Euro Biom is an MHRA-licensed UK pharmaceutical supplier working with Sri Lankan tertiary hospitals, the National Hospital in Colombo, private clinics and the State Pharmaceuticals Corporation sourcing UK-origin branded, specialty, named patient and shortage medicines. We hold WDA wholesale dealer authorisation, stock over 5,800 products, and prepare every export to the standards NMRA and Sri Lanka Customs require.
Why Sri Lankan Hospital Buyers Struggle to Source UK Medicines
Sri Lanka's pharmaceutical import environment is centred on NMRA registration and a waiver system for unregistered medicines. Most UK wholesalers do not understand what NMRA actually asks for, and hospital pharmacy teams pay the price in delays.
NMRA Waiver Applications Are Case-Specific
For unregistered medicines, Sri Lankan treating physicians and hospitals apply to NMRA for a waiver allowing case-by-case import. The waiver requires a UK supplier with verifiable MHRA credentials and documentation structured to NMRA expectations. Most UK wholesalers do not prepare paperwork in the form NMRA needs.
Colombo Customs Is Strict on Documentation
Sri Lanka Customs at Bandaranaike International checks Certificate of Pharmaceutical Product, GMP certificates and GDP chain of custody carefully. Consignments with inconsistent or incomplete paperwork are held or returned, and refrigerated stock cannot wait.
Foreign Exchange and SPC Procurement Complexity
Sri Lanka's State Pharmaceuticals Corporation (SPC) manages much of the public-sector procurement, and private hospital imports navigate foreign exchange controls. UK suppliers without the operational flexibility to work with SPC tender structures or private hospital payment flows simply cannot serve the market.
Indirect Routing Creates Cold Chain Risk
There are no direct Heathrow to Colombo flights. Shipments route via Dubai, Doha or Singapore with ground time at transit hubs adding cold chain risk. For biologics and oncology products, validated containers and continuous monitoring are essential.
Oncology Urgency at National Hospital and Private Centres
The National Hospital in Colombo and private tertiary centres frequently need UK-origin targeted therapies or biologics on tight clinical timelines. Most UK exporters treat Sri Lanka as a secondary market and cannot respond fast enough to matter clinically.
Single Accountability for Complex Import Cases
Sri Lankan hospital pharmacy teams need one UK partner who owns the shipment from Heathrow to Colombo, prepares every NMRA document, and takes the call when Sri Lanka Customs needs a clarification. Most UK wholesalers cannot provide that.
An MHRA-Licensed UK Wholesaler Built for Sri Lankan Hospital Supply
Importing a specialty or named patient medicine into Sri Lanka should be traceable, NMRA-compliant and fast. Whether you are a consultant at the National Hospital sourcing a waiver medicine, a private oncology centre managing a biologic case, or an SPC-authorised importer handling a tender contract, we manage the UK side so your team can focus on the patient.
We hold MHRA Wholesale Dealer Authorisation WDA(H) 59239, stock over 5,800 medicines across 21 therapeutic areas, and prepare every shipment with NMRA-aligned documentation. Every Certificate of Pharmaceutical Product, batch Certificate of Analysis and GDP record is structured to clear Colombo customs on the first attempt.
Based at Heathrow, we dispatch via Gulf or Singapore hub air freight to Colombo with validated cold chain containers and continuous monitoring. For NMRA waiver and urgent shortage cases, we respond the same day and dispatch within 24 to 48 hours once documentation is cleared.
Discuss Your RequirementsWhy Sri Lankan Hospital Buyers Choose Euro Biom
Practical reasons tertiary hospitals, oncology centres and private clinics across Sri Lanka work with us for UK-origin medicines.
Publicly Verifiable MHRA Licence
WDA(H) 59239 on the UK MHRA public register. Your NMRA and hospital procurement teams verify us in under a minute. No phantom wholesalers, no unverifiable credentials, no friction at waiver supplier review.
NMRA-Aligned Export Documentation
Certificate of Pharmaceutical Product, Certificate of Free Sale, GMP certificates, batch-level Certificate of Analysis and GDP chain of custody, all prepared to the structure NMRA and Sri Lanka Customs actually check.
Waiver Application Expertise
We understand what Sri Lankan treating physicians and hospital pharmacies need on the UK side to support an NMRA waiver application. Clean documentation, traceable provenance, immediate dispatch once the waiver is approved.
Oncology and Specialty Sourcing
Active sourcing of UK-origin targeted therapies, biologics and specialty oncology products for Sri Lankan tertiary hospitals and private centres. Traceable GMP provenance with full chain of custody.
We Hold Actual Stock
5,800+ pharmaceutical products in active UK warehouse stock. When we confirm availability for a Sri Lankan case, the medicine is physically here and ready for dispatch, not a speculative promise.
Cold Chain via Gulf or Singapore Hub
Validated temperature-controlled containers with continuous monitoring from Heathrow through Dubai, Doha or Singapore to Colombo. Transit hub handling protocols reduce ground time exposure.
Same-Day Response for Urgent Cases
When a Sri Lankan hospital needs UK-sourced medicine urgently, we confirm stock the same day and dispatch within 24 to 48 hours. Clinical timelines, not email-ticket timelines.
One Accountable Point of Contact
Single point of contact from enquiry through to arrival at your hospital pharmacy in Colombo. One thread, full visibility, no handoffs when NMRA or Sri Lanka Customs raises a question.
Pharmaceutical Supply Services for Sri Lanka
Four service lines built around what Sri Lankan tertiary hospitals, private centres and SPC importers actually face when sourcing UK-origin medicines.
NMRA Waiver Named Patient Supply
For Sri Lankan treating physicians and hospitals sourcing unregistered medicines under NMRA waiver. We provide UK-side sourcing from verified GMP manufacturers, documentation structured for NMRA, and immediate dispatch once the waiver is approved.
- NMRA waiver documentation support
- UK GMP manufacturer sourcing
- Oncology, rare disease and specialty products
- Same-day response for urgent cases
Oncology and Biologic Supply
For the National Hospital Colombo, private tertiary centres and oncology units sourcing UK-origin targeted therapies, monoclonal antibodies and biologics. Validated cold chain via Gulf or Singapore hub with continuous temperature monitoring.
- Targeted therapies and monoclonal antibodies
- Validated cold chain via hub routing
- NMRA-aligned customs documentation
- Batch-level Certificate of Analysis provided
SPC and Hospital Procurement Support
For SPC-authorised importers and private hospital procurement teams sourcing UK medicines under tender contracts or direct purchase agreements. Branded and generic medicines with NMRA-aligned documentation and consistent delivery timelines.
- SPC tender documentation support
- Private hospital and clinic procurement
- NMRA documentation included
- Consistent recurring supply
Shortage and Emergency Medicine Supply
When a Sri Lankan tertiary hospital faces a shortage, we provide UK-sourced alternatives with same-day stock confirmation and dispatch within 24 to 48 hours. Validated cold chain via hub routing with full temperature log on arrival.
- Same-day response for urgent shortage requests
- UK-sourced alternatives with traceable provenance
- Direct Heathrow dispatch
- Full GDP-compliant documentation
Trusted by Sri Lankan Hospital Buyers
Procurement teams and treating physicians at tertiary hospitals and private centres in Colombo and across Sri Lanka have chosen Euro Biom for UK-origin medicine supply.
"Euro Biom supported our NMRA waiver application with exactly the documentation we needed. The medicine cleared Colombo customs without a single query and the patient started treatment the day after arrival. That is the service level that actually matters."
"Their MHRA licence is verifiable in under a minute and their cold chain handling via the Dubai hub was professional throughout. Temperature logs arrived with the shipment and the product was in full spec on arrival."
"For an urgent oncology case they confirmed UK stock the same morning and had it on a plane within 48 hours. Clean documentation, clear communication, no surprises. We keep them as a first-call UK partner."
Our Process for Sri Lankan Pharmaceutical Supply
From first enquiry to arrival at your hospital pharmacy in Colombo, the process is built to be fast, traceable and NMRA-compliant.
Step 1: Enquiry and UK Stock Check
You send the medicine name, strength, quantity and clinical context. We confirm UK warehouse stock the same day, quote in GBP or USD, and outline the documentation bundle for NMRA waiver submission.
Step 2: NMRA Documentation Bundle
We prepare Certificate of Pharmaceutical Product, GMP certificates, batch-level Certificate of Analysis, Certificate of Free Sale and full GDP chain of custody, structured to NMRA standards for Sri Lanka Customs clearance.
Step 3: Cold Chain Dispatch via Hub
Once payment and waiver are confirmed, we dispatch from Heathrow via Dubai, Doha or Singapore to Colombo. Temperature-sensitive products travel in validated containers with continuous monitoring throughout transit and hub ground time.
Step 4: Customs Clearance and Delivery
We remain available throughout Sri Lanka Customs clearance to respond to NMRA or customs queries directly. Once cleared, onward delivery to your hospital pharmacy is coordinated with your chosen Sri Lankan logistics partner.
Sri Lanka Pharmaceutical Market Insight
Sri Lanka's well-established healthcare system and NMRA regulatory framework create clear import pathways for UK medicines.
Sri Lanka's pharmaceutical market, valued at approximately USD 1.1 billion in 2024, serves a population of 22 million through one of the most established public healthcare systems in South Asia. The country's National Medicines Regulatory Authority (NMRA), established under the NMRA Act No. 5 of 2015, regulates all pharmaceutical imports and maintains standards that are well-regarded internationally. Sri Lanka achieves health outcomes significantly above its income level, life expectancy of 77 years, universal free healthcare in the public sector, and a network of over 600 government hospitals.
Sri Lanka's pharmaceutical import process is managed through the NMRA registration system. For registered medicines, the standard evaluation takes 180 to 365 days. For unregistered medicines required for specific patients, the NMRA operates a Special Import Licence (SIL) pathway under Section 89 of the NMRA Act, this allows hospital consultants to apply for individual import permits for medicines not available on the local market. Euro Biom supplies UK-origin medicines through this pathway, providing the MHRA licence documentation, Certificate of Pharmaceutical Product, and batch certificates that NMRA requires.
The country's State Pharmaceuticals Corporation (SPC) handles the majority of public sector medicine procurement through competitive tender. However, specialty medicines, orphan drugs, and named patient therapies fall outside the standard SPC procurement, these are sourced through the SIL pathway from international suppliers. Private sector hospitals, including Asiri Group, Lanka Hospitals, Durdans, and Nawaloka, also import medicines directly through NMRA-approved channels for their patients.
Key therapeutic areas driving UK pharmaceutical import demand in Sri Lanka include oncology (the National Cancer Control Programme at Maharagama serves as the primary treatment hub, with cancer incidence rising steadily), nephrology (Sri Lanka has unusually high chronic kidney disease prevalence, particularly in the North Central and Uva provinces, a phenomenon known as CKDu that has drawn WHO attention), cardiology, and neurology. The country's expanding NCD screening programmes under the Healthy Lifestyle Centres initiative are increasing early detection and consequently driving demand for imported specialist medicines.
Frequently Asked Questions About UK Medicine Supply to Sri Lanka
Practical questions from Sri Lankan hospital pharmacy teams, oncology consultants and SPC importers, answered plainly.
Need a UK Pharmaceutical Supplier for Sri Lanka
Same-day response. MHRA-licensed. NMRA-aligned documentation. Direct dispatch from Heathrow to Colombo via Gulf or Singapore hub. Tell us the medicine, the clinical context and the timeline. We will tell you within hours whether we can help.
MHRA WDA(H) 59239 · Company No. 15380737 · Registered England and Wales · work@eurobiom.co.uk